BT
Therapeutic Areas
Coeptis Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| COEP-001 | Relapsed/Refractory B-cell Malignancies (e.g., NHL, ALL) | Phase 1 |
| DARIC-NK Program | Hematologic Malignancies | Preclinical |
| SNAP-CAR Solid Tumor Programs | Solid Tumors | Discovery/Preclinical |